Last reviewed · How we verify

NCT03384758

Evaluation of Compression Therapy in Patients With Mild to Moderate PAD or Diabetes Mellitus

Completed NA Last updated 8 May 2020
What this trial tests

NA trial testing Compression Therapy in Peripheral Arterial Disease in 94 participants. Completed in 1 March 2019.

Timeline
1 May 2018
Primary endpoint
1 February 2019
1 March 2019

Quick facts

Lead sponsorUniversity Hospital Erlangen
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment94
Start date1 May 2018
Primary completion1 February 2019
Estimated completion1 March 2019
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital Erlangen

Who can join

18 and older, any sex, with Peripheral Arterial Disease or Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of this prospective clinical study is the Evaluation of the Effect of Compression Therapy on the Microcirculation in Patients With Leg Edema and Mild to Moderate PAD or Diabetes Mellitus.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Safety of medical compression stockings in patients with diabetes mellitus or peripheral arterial disease.
    Rother U, Grussler A, Griesbach C, Almasi-Sperling V, et al · · 2020 · cited 13× · PMID 32503811 · DOI 10.1136/bmjdrc-2020-001316

Verify or expand the search:

Other trials of Compression Therapy

Trials testing the same drug.

Other recruiting trials for Peripheral Arterial Disease

Currently open trials in the same condition.

Other University Hospital Erlangen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03384758.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing